chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1. immediate swelling, red, hot arm for 2 days (obvious allergic or immune response) 2. within hours Flu like feeling immediately with no temp (expected this) still have this 3+ weeks later 3. bloody nose for 1 hour on day 3 4. headache - constant for 23 days straight 5. dizzyness, cloudiness - still 23 days later 6. extreme fatigue - still 23 days later 7. metal taste in mouth, sore teeth - still 23 days later 8. body ache all over - still 23 days later 9. sub-temp of 95-97 every day - still 23 days later (I always run normal) 10. occasional nausea - still 23 days later 11. tinnitus - worsening every day - now audible over ambient noise 12. sore throat, dry cough - still 23 days later 13. mild shortness of breath - still 23 days later  I am an extremely healthy 61 year old who has never been sick beyond basic stuff like cold or flu, NEVER been hospitalized and exercises abundantly with softball, pickleball, biking (inside and out), hiking, skiing,  Orange Theory (tough!) fitness workout 2-3 times a week, avid runner, etc.)  I cannot do these things.  It makes me want to throw up or faint.  I walk and am extremely fatigued.  The constant headache is driving me insane.  I NEVER get headaches.  I finally called my doc on day 8 because this is just not right.  I had the two Moderna vaccines March 2021 and September 2021.  I was a little sore for 24 hours but NOT like this.  This was the booster shot (#3).  I will NEVER get the vax or Moderna again.
Diffuse red, blotchy, non raised rash noted on stomach, breasts, flank area 36 hours after COVID vaccine. Non-itchy, non-painful, no blisters. Still present 12 days after vaccine.
I was fatigue and I had a whelp and the doctor referred to it as Covid arm . My arm was swollen and hard, It lasted a week before it stopped hurting.
Rash - erythema multiforme 5 days after flu vaccine given. Patient on prednisone and rash improving.
Pt. states neck swelling occurred 2/27/11 and increased on 2/28/11.
Patient went to provider with swelling and pain in her shoulder, and flu-like symptoms. Provider diagnosed her with bursitis.
Pt's wife mentioned that her husband was hospitalized 1 month after receiving flu shot and that the neurologist thought that it might be Guillain-Barre Syndrome and that it may be from the flu shot. We have not spoken to the doctor. Wife has come in a few times afterwards but has not mentioned anything else. 1/29/2010 Patient had found out later he had had a stroke in his spinal cord. They ruled out the flu shot as being the course of paralysis. He has since passed away due to complications from sepsis.  3/9/09 Received hospital medical records of 11/13/2008-11/25/2008 FINAL DX: No d/c summary available.  Recent onset paraplegia; spinal vascular malformation, unlikely GBS. Records reveal patient experienced s/s as noted above including progressive parapesis, sensory loss & bowel/bladder dysfuntion, paraplegia T8 & had been transferred from outlying hospital.  Admitted to ICU & continued on steroids.  Neuro, Neurosurg, Medicine, Heme, Nephro & Uro consults done.  12/11/08 Reviewed hospital medical records of 10/29-11/7/08. FINAL DX: Guillain Barre syndrome; paraplegia; atrial fib; ileus; urinary retention. Records reveal patient experienced Gi symptoms & URI approx 1 wk prior to admit.  On admit had LE numbness & weakness, areflexia. Neuro & cardio consults done. Tx w/plasmapheresis.  Transferred to inpatient rehab.  Worsened & returned to acute care 11/10 for further treatment & evaluation.  1/23/09 Reviewed hospital medical records of 11/9-11/12/2008. FINAL DX: paraplegia perhaps secondary to some spinal cord hemorrhage Records reveal patient experienced initial leg weakness that rapidly progressed to complete paralysis which had been dx as GBS.  Pt had been transferred to rehab where neurologists felt presentation atypical for GBS & repeated MRI which revealed possible bony metatases & spinal cord abnormality.  Readmitted to acute care where exam revealed complete paralyisis & anesthesis from waist down w/loss of bowel & bladder control.  Transferred to higher level of care.
face rash; Increased heart rate; trouble breathing; dizziness; This is a spontaneous report from a contactable other healthcare professional (patient). A 21-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EM9809) dose 1 via an unspecified route of administration, administered in Arm Left on 05Feb2021 18:15(at the age of 21 years old) as single for COVID-19 immunisation at workplace clinic. Medical history included covid-19 from an unknown date and unknown if ongoing prior to vaccination. The patient's concomitant medications were not reported. The patient previously took amoxicillin and experienced drug hypersensitivity. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 05Feb2021 18:30 the patient experienced Increased heart rate, trouble breathing, dizziness, and face rash. Treatment were received for events with allergy medicine. Since the vaccination, the patient was not tested for COVID-19. Outcome of all the events were recovering.  Follow-up attempts are completed. No further information is expected.
left eye -inner muscle pain corner of eye socket  and towards the nose upwards during mid sleep, light redness, pain lasting all day, vision blurred.  Never had an eye problem before or computer/tv before sleep. I avoided sleeping on left arm, on my back, and woke twice with soreness building by 8am., eye was red and painful to touch the inner corner socket and nose muscle. After washing the pain stayed and the lid was slightly dropped, vision 25% blurred and pain during closing of eye, muscles felt tighten. All lasted the full day.
A pharmacist reported that a pt received vaccine on 5/1/2000, or 5/2. 15 to 30 minutes later pt developed severe cellulitis at the injection site. Pt was seen by physician who prescribed a single IV dose of Cefazolin.
This is a spontaneous report from a contactable consumer. A patient, of unspecified age and gender, received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# unknown), via an unspecified route of administration, on an unspecified date (Saturday), single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. On an unspecified date (Tuesday and on that day), patient broke-out in rashes on legs, thighs, buttocks and on arm; with outcome of unknown. Information on the lot/batch number requested.
Received shot (only one vaccine) at about 10:50 AM. Felt a little dizzy right after for a few min. Arm began to hurt about an hour after, but by bedtime was VERY painful. Did not sleep, felt nausea, headache and ached.
Patient received vaccine on 2/3/21. Developed headache, fever and red warm rash to injection site on 2/21/2021. Applied ice and took Tylenol. Symptoms starting to resolve today
3 weeks after receiving the booster, I started having stomach pain. This lead to mucus in my stool within 4 weeks after booster. Within 6 weeks after receiving the booster I had blood in my stool. I met with my primary care physician who referred me to my gastroenterologist. I was then scheduled for an colonoscopy in February if 2022.
Large red welt appeared on arm at injection site.  As of today's date a red mark is still visible at injection site.
2 inch diameter erythematous raised wheal on upper right arm, no s/s of infection.
Left upper arm with 10x7 cm faint erythema surrounding 3x3 cm induration with control puncture mark.  Area is sensitive to touch.
worse side effects than the previous side effects with 1st dose and 2 dose; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (worse side effects than the previous side effects with 1st dose and 2 dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (worse side effects than the previous side effects with 1st dose and 2 dose). At the time of the report, VACCINATION COMPLICATION (worse side effects than the previous side effects with 1st dose and 2 dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-335598, MOD-2021-335665 (Patient Link).
Shot 11/3/06 fever 103 11/4/ PM, 11/6 PM 104. Redness of site 11/5, worsening 11/7/06
Breakthrough case admission after 3 vaccines  Pfizer 10/12/21 Lot# FF2587;  Pfizer 5/9/22 Lot# FJ4989;  Pfizer 10/7/22 Lot# GJ2524
losing patches of hair due to alopecia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 03Feb2021 at 12:00 as dose 2, single (Lot number: EL3249) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL]; WIXELA INHUB; SAM-E. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Batch/Lot No: EL3246, Location of injection: Arm Left, Vaccine Administration Time: 12:00), administration date: 13Jan2021, when the patient was 43-year-old, for Covid-19 immunization. The following information was reported: ALOPECIA (medically significant) with onset 01Mar2021 at 12:00, outcome "not recovered", described as "losing patches of hair due to alopecia". The event "losing patches of hair due to alopecia" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of alopecia.  Clinical course: "Soon after getting vaccinated I started losing patches of hair due to alopecia. I had to shave my head due to it after a few months". Ae treatment with Steroid Shots and topical medications. Patient had no covid prior vaccination.
The patient came to the clinic to receive her second dose of Moderna. But, she was given a booster dose of Moderna. Contacted her to come back to clinic to receive the rest of the dose for second dose.
Second dose of vaccine to be administered past day 36; This spontaneous case was reported by a consumer and describes the occurrence of OFF LABEL USE (Second dose of vaccine to be administered past day 36) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OFF LABEL USE (Second dose of vaccine to be administered past day 36). At the time of the report, OFF LABEL USE (Second dose of vaccine to be administered past day 36) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment and concomitant medicines were not reported  Action taken with mRNA-1273 in response to the event was unknown
81 y/o otherwise healthy female on no prescription medications Received Moderna Covid 19 vaccine on 2/25/2021 at 11:30 am -- > no problems following administration of vaccine  About 15 hours later, on 2/26/2021 at around 2:30 am, pt went into the shower and suddenly felt acutely weak in lower extremities; unable to bear weight, so sat down on floor; no fall or injury; no focal neurologic sx at that time.   Patient was able to crawl out of bathtub and call family member - total time down about 3 hours.   Patient denied any associated fever, chest pain or upper body weakness.   Due to extreme lower extremity weakness, pt taken to ER -- > dx:  nontraumatic rhabdomylolysis She was treated with IVF, Tylenol and discharged home.   Since discharge, she has been steadily improving.   Three days after ER, pt is able to bear weight, ambulate but still with mild bilateral upper thigh pain and weakness (unable to get up from low seated position or squat).
Administered MMRV to her daughter, daughter moved and part of the vaccine went into mothers right eye.  Right eye was irrigated with eye wash. Client instructed to report if develops any s/s and seek medical treatment for s/s.
Swelling and hardness at the injection site, redness at and around injection site, arm weakness and heaviness, itchiness.
she missed the 2nd dose; Fever; This is a spontaneous report from a Pfizer-sponsored program Support. A contactable Female consumer (patient) reported that. A female patient of an unspecified age received first dose of BNT162B2 (formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 26Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported she received the 1st dose on 26Mar2021, but she missed the 2nd dose which was supposed to be on 26Apr2021 because she had a fever. She is inquiring how to reschedule the 2nd dose. Confirmed the patient received the Pfizer-BioNTech COVID-19 vaccine. Cold transferred to  due to the long wait time and Cold transferred to  due to the long wait time. Were any medical questions addressed by this program forwarded/referred to Medical Information was not applicable. The patient experienced she missed the 2nd dose and fever on an unspecified date. The clinical outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
pt recv vax 16OCT96 & 1JUN97 pt devel chickenpox;
Information has been received from a health professional concerning a 10 year old female who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot# 659610/1654U). On 10-JAN-2008 the patient experienced injection site redness and swelling. Subsequently, the patient recovered. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested. Follow up information from a health care professional indicated that on 11-Jan-2008, the patient developed red, large, swelling upper arm area that was also hot. Treatment was reported, on 14-JAN-2008, the patient had recovered. This is one of several reports from the same source. Additional information is not expected.
rash on forearms, top of legs, chest and back; fatigue; headache; slight fever; little shivering; muscle soreness; stomach upset; This case was reported by a consumer via call center representative and described the occurrence of fatigue in a 60-year-old female patient who received Shingrix (batch number EH9Z7, expiry date 8th March 2021) for prophylaxis. On 9th October 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 10th October 2018, 1 days after receiving Shingrix, the patient experienced fatigue, headache, fever, shivering, muscle soreness and upset stomach. On 11th October 2018, the patient experienced generalized rash. On an unknown date, the outcome of the fatigue, headache, fever, shivering, muscle soreness and upset stomach were recovering/resolving and the outcome of the generalized rash was not recovered/not resolved. It was unknown if the reporter considered the fatigue, headache, fever, shivering, muscle soreness, upset stomach and generalized rash to be related to Shingrix. Additional details were reported as follows: The reporter stated that next day (10th October 2018) after receiving shingrix she experienced fatigue, headache, slight fever, a little shivering, muscle soreness, and a little stomach upset. The reporter stated that these symptoms were better at the time of reporting but not completely resolved. The reporter stated that at the time of reporting (11th October 2018) 2 days after receiving shingrix she noticed that she was developing a rash on her forearms, top of her legs, chest and back.
Hospitalized. Hypoxic, given oxygen; dexamethasone, remdesivir, albuterol
Received Covid vaccine at 4:00 PM.  At 4:45 developed sharp, acute, shooting pain behind right ear near bottom.  At about 6:15 PM contacted a relative who is an active nurse at a local hospital.  She said problem was a swollen lymph node and to ice it and take Tylenol if desired.  I iced it for 15 minutes and took two high strength Tylenol at about 6:30 PM.  Pain stopped at 7:00 PM.  Pain returned at 10:00 PM and I reapplied ice for 25 minutes (did not take any more Tylenol).  When ice was removed, pain had stopped.  Went to bed and awoke at about 12:30 AM and 3:00 AM with no pain.  No more pain throughout today.
Patient was apprehensive about shot.  Discussed common side effects-sore arm & flu like symptoms and recommended to sit 15 minutes after shot.  Patient received shot. Sat but felt bad, went to counsel window to let us know.  Feel and hit head as he headed back.
Dizziness. Has history of dizziness, did not hydrate herself today. Given water, BP/HR improved. Stable, released from vaccination site.
#1 I had reaction to Moderna first (Jan 22) and 3 MDs told me to get J&J as second A few hours following shot developed dry cough, which persisted  4 days. Within 3 hours developed moderate headache which lasted 4 days. After 7 hours became EXTREMELY cold. Had to stay in bed w 7 blankets for 2 days. By 3 days still chilly but relenting. Mild to sometimes moderate nausea developed first day, lessening over 3 days. Fatigue severe starting 8 hours post vaccine, resolving over 4 days. Tiny bit of injection site pain.
Severe muscle aches. They started at around 9 hours after the vaccine and continued for 48 hours. The intensity decreased eventually, but it was very painful.
Bad hives on body.... still has them today! Got them after he had the shot! No recovery so far.
Generalized muscle stiffness, fever 103.2 started approximately 5 hrs. after receiving flu and pneumonia vaccines (pt requested both injections in left deltoid).
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.  Date of refrigeration of vial was 7 May 2021.
I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R57.0 CARDIOGENIC SHOCK 6/25/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY R57.0 CARDIOGENIC SHOCK 6/25/2021 SYSTOLIC HEART FAILURE, UNSPECIFIED ACUITY I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 ATRIAL FIBRILLATION, PAROXYSMAL R57.0 CARDIOGENIC SHOCK 6/25/2021 ATRIAL FIBRILLATION, PAROXYSMAL I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 AORTIC VALVE STENOSIS R57.0 CARDIOGENIC SHOCK 6/25/2021 AORTIC VALVE STENOSIS I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 AORTIC VALVE STENOSIS R57.0 CARDIOGENIC SHOCK 6/25/2021 AORTIC VALVE STENOSIS I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/28/2021 ISCHEMIC CARDIOMYOPATHY W UNSPECIFIED CHF STAGE C R57.0 CARDIOGENIC SHOCK 6/25/2021 ISCHEMIC CARDIOMYOPATHY W UNSPECIFIED CHF STAGE C
returned to clinic 25 minutes later for fussiness, redness, swelling of the face. airway patent, afebrile, no lethargy/syncope, tachypnea, hypoxia, reflexes intact given diphenhydramine at 17:53, observed 20 minutes, swelling resolved, fussiness reduced. New rx for  diphenhydramine sent to the pharmacy  pt informed to call 911 if sxs worsen.
A 49 year old female experienced fatigue and arm pain on 28-NOV-2000 following vaccination with RabAvert for post exposure prophylaxis. Three or four days before her first RabAvert injection (21-NOV-2000), the pt was providing food to a raccoon and was bitten on the bottom of her left hand. She received a small "barely broken" skin wound which she cleaned with hydrogen peroxide and alcohol. At the time of this report, 10-JAN-01 she has since seen the raccoon alive. The pt was vaccinated with RabAvert on 21-NOV-2000 in the deltoid and also treated with human rabies immune globulin in the hips. No adverse events occurred. On 25-NOV-2000, she was vaccinated at a different clinic in her hips. She experienced fatigue. On 28-NOV-2000, she was vaccinated with her third vaccination in the arm. She experienced fatigue and arm pain at the injection site, sweating which she felt was "hormonal", headaches which she has recovered from and an achy jaw which she stated was from her history of temporomandibular joint disorder. the pt stated that her achy jaw symptoms improved with treatments from her chiropractor. On 05-DEC-2000 and 19-DEC-2000 she received her fourth and fifth vaccinations respectively and experienced weakness and arm pain at the injection sites both times. She stated that her fatigue has improved but she has not fully recovered. her arm pain and weakness are still persisting. Around 08-JAN-2001, the pt experienced weakness in the legs, back and neck which she does not feel is due to the RabAvert vaccinations. Her physician states that he will investigate possible rheumatoid arthritis or lupus.
Patient seen in the ED and admitted for weakness. Tested positive for COVID-19 on  6/20/2022 via PCR. This meets criteria for vaccine breakthrough case review.
Patient arrives very nervous to get the vaccine, she was very scared. She was given the vaccine at 3:10PM and at 5 minutes (3:15PM) she begins to complain that she is dizzy, then says she feels nauseous and begins to shake. I proceed to take his blood pressure and he had 128/89 and a pulse at 126. He called 911 and when they arrived they checked his blood pressure and sugar levels and everything came out normal. Paramedics took her to the hospital. At 6:00PM, an Medical Staff came to inform us that she had contacted the patient and she informed her that she was fine and that the doctor told her that it was the fright that caused the reaction.